ALBIREO PHARMA INC (ALBO) Stock Income Statement
USA - NASDAQ:ALBO - US01345P1066 - Common Stock
44.15 USD
-0.1 (-0.23%)
44.33 USD
+0.18 (+0.41%)
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 57.39M | 40.58M | 8.31M | 9.64M | 12.74M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 2.55M | 1.36M | null | null | null | |||
| Gross Profit | 54.84M | 39.22M | null | null | null | |||
| Operating Expenses | 177.76M | 162.71M | 104.58M | 70.75M | 50.63M | |||
| Research and Development | 88.70M | 82.52M | 76.78M | 45.58M | 31.73M | |||
| Selling, General, and Administrative Expenses | 78.76M | 69.57M | 42.45M | 22.96M | 18.06M | |||
| Operating Income | -122.91M | -123.48M | -96.27M | -61.11M | -37.89M | |||
| Interest Income/Expense | -11.41M | -13.93M | -11.36M | -5.30M | -4.84M | |||
| Other Income/Expense | null | 103.39M | 0 | 3.69M | -3.36M | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -134.93M | -34.03M | -107.63M | -62.72M | -46.09M | |||
| Income Tax | null | null | null | 0 | 20.00K | |||
| Net Income | -131.15M | -34.03M | -107.63M | -62.72M | -46.11M | |||
| EBITDA | -122.48M | -123.21M | -96.08M | -60.98M | -37.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -6.72077 | -1.77047 | -6.73 | -5.04 | -3.94 | |||
| Non GAAP EPS | -6.720000000000001 | -6.78 | -6.869999999999999 | -5.35 | -3.8799999999999994 | |||
| Statistics | ||||||||
| Gross Profit Margin | 95.56% | 96.66% | N/A | N/A | N/A | |||
| Profit Margin | -228.51% | -83.86% | -1295.19% | -650.62% | -361.93% | |||
| Operating Profit Margin | -214.17% | -304.31% | -1158.48% | -633.92% | -297.41% | |||
All data in USD